Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Total Current Liabilities: 2020-2024

Historic Total Current Liabilities for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $295.5 million.

  • Cellebrite DI's Total Current Liabilities rose 16.12% to $316.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $316.9 million, marking a year-over-year increase of 16.12%. This contributed to the annual value of $295.5 million for FY2024, which is 16.42% up from last year.
  • Per Cellebrite DI's latest filing, its Total Current Liabilities stood at $295.5 million for FY2024, which was up 16.42% from $253.8 million recorded in FY2023.
  • Cellebrite DI's Total Current Liabilities' 5-year high stood at $295.5 million during FY2024, with a 5-year trough of $159.4 million in FY2020.
  • For the 3-year period, Cellebrite DI's Total Current Liabilities averaged around $252.4 million, with its median value being $253.8 million (2023).
  • Data for Cellebrite DI's Total Current Liabilities shows a peak YoY climbed of 22.16% (in 2023) over the last 5 years.
  • Over the past 5 years, Cellebrite DI's Total Current Liabilities (Yearly) stood at $159.4 million in 2020, then climbed by 17.06% to $186.6 million in 2021, then grew by 11.36% to $207.8 million in 2022, then climbed by 22.16% to $253.8 million in 2023, then increased by 16.42% to $295.5 million in 2024.